Total trials
80
Active
12
Phase 3
5
Total enrollment
9,964
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Tranexamic Acid | — | — | — | — | — | 2 | |
| Ibuprofen 400 mg, TID | — | — | — | — | — | 1 | |
| oral ketamine | — | — | — | — | — | 1 | |
| oxycodone | — | — | — | — | — | 1 |
Next readouts
- 2021-01-01
- 2026-03-01
- 2026-12-31
Top conditions
- Patent Ductus Arteriosus4
- Prostate Cancer3
- Chronic Pain3
- Neuropathic Pain3
- PSA2
- Sarcoidosis2
- Cesarean Section2
- Pain, Postoperative2
Frequently asked questions about Albany Medical College
- How many clinical trials does Albany Medical College have on ClinicalTrials.gov?
- Albany Medical College is listed as the lead sponsor on 80 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Albany Medical College's trials are in Phase 3?
- 5 of Albany Medical College's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Albany Medical College focus on?
- Albany Medical College's most-studied conditions on ClinicalTrials.gov are Patent Ductus Arteriosus, Prostate Cancer, Chronic Pain, Neuropathic Pain, PSA.
- When are Albany Medical College's next clinical trial readouts?
- Albany Medical College has 3 upcoming primary-completion readouts tracked here; the soonest is “Tranexamic Acid Infusion During Elective Spine Surgery”, expected around 2021-01-01.